Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 184

1.

Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry.

Pacifici R, Marchei E, Salvatore F, Guandalini L, Busardò FP, Pichini S.

Clin Chem Lab Med. 2017 Feb 16. pii: /j/cclm.ahead-of-print/cclm-2016-1060/cclm-2016-1060.xml. doi: 10.1515/cclm-2016-1060. [Epub ahead of print]

PMID:
28207408
2.

Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.

Babalonis S, Haney M, Malcolm RJ, Lofwall MR, Votaw VR, Sparenborg S, Walsh SL.

Drug Alcohol Depend. 2017 Mar 1;172:9-13. doi: 10.1016/j.drugalcdep.2016.11.030.

PMID:
28088032
3.

A user's guide to cannabinoid therapies in oncology.

Maida V, Daeninck PJ.

Curr Oncol. 2016 Dec;23(6):398-406. doi: 10.3747/co.23.3487. Review.

4.

Evolution of multiple sclerosis spasticity-associated symptoms: latest data.

Flachenecker P.

Neurodegener Dis Manag. 2016 Dec;6(6s):9-12.

PMID:
27874495
6.

Targeting the Endocannabinoid System in Psychiatric Illness.

Katzman MA, Furtado M, Anand L.

J Clin Psychopharmacol. 2016 Dec;36(6):691-703.

PMID:
27811555
7.

Cannabidiol: a potential treatment for post Ebola syndrome?

Reznik SE, Gardner EL, Ashby CR Jr.

Int J Infect Dis. 2016 Nov;52:74-76. doi: 10.1016/j.ijid.2016.09.020.

8.

Medical Marijuana: Just the Beginning of a Long, Strange Trip?

Ciccone CD.

Phys Ther. 2016 Sep 22. [Epub ahead of print]

PMID:
27660328
9.

Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes.

Lehmann C, Fisher NB, Tugwell B, Szczesniak A, Kelly M, Zhou J.

Clin Hemorheol Microcirc. 2016;64(4):655-662. doi: 10.3233/CH-168021.

PMID:
27767974
10.
11.

Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes.

Peace MR, Butler KE, Wolf CE, Poklis JL, Poklis A.

Front Pharmacol. 2016 Aug 29;7:279. doi: 10.3389/fphar.2016.00279.

12.

Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.

Davis MP.

J Natl Compr Canc Netw. 2016 Jul;14(7):915-22. Review.

PMID:
27407130
13.

Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice.

Harris HM, Sufka KJ, Gul W, ElSohly MA.

Planta Med. 2016 Aug;82(13):1169-72. doi: 10.1055/s-0042-106303.

PMID:
27214593
14.

Endocannabinoid System: A Multi-Facet Therapeutic Target.

Kaur R, Ambwani SR, Singh S.

Curr Clin Pharmacol. 2016;11(2):110-7. Review.

PMID:
27086601
15.
16.

Cannabinoids: Medical implications.

Schrot RJ, Hubbard JR.

Ann Med. 2016;48(3):128-41. doi: 10.3109/07853890.2016.1145794. Review.

PMID:
26912385
17.

Medicinal cannabis.

Murnion B.

Aust Prescr. 2015 Dec;38(6):212-5. Review.

18.

[Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].

Petzke F, Enax-Krumova EK, Häuser W.

Schmerz. 2016 Feb;30(1):62-88. doi: 10.1007/s00482-015-0089-y. German.

PMID:
26830780
20.

Medical use of cannabis products: Lessons to be learned from Israel and Canada.

Ablin J, Ste-Marie PA, Schäfer M, Häuser W, Fitzcharles MA.

Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.

PMID:
26767992
Items per page

Supplemental Content

Loading ...
Support Center